[(2S,3S,5R)-5-{4-amino-3-[(4-methylphenyl)sulfanyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate

ID: ALA4462359

Chembl Id: CHEMBL4462359

PubChem CID: 147538678

Max Phase: Preclinical

Molecular Formula: C17H20N6O5S2

Molecular Weight: 452.52

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(Sc2nn([C@H]3C[C@H](O)[C@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)cc1

Standard InChI:  InChI=1S/C17H20N6O5S2/c1-9-2-4-10(5-3-9)29-17-14-15(18)20-8-21-16(14)23(22-17)13-6-11(24)12(28-13)7-27-30(19,25)26/h2-5,8,11-13,24H,6-7H2,1H3,(H2,18,20,21)(H2,19,25,26)/t11-,12-,13+/m0/s1

Standard InChI Key:  FOLVWTRUBGSTBX-RWMBFGLXSA-N

Alternative Forms

  1. Parent:

    ALA4462359

    ---

Associated Targets(Human)

ATG7 Tchem Ubiquitin-like modifier-activating enzyme ATG7 (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 452.52Molecular Weight (Monoisotopic): 452.0937AlogP: 0.74#Rotatable Bonds: 6
Polar Surface Area: 168.47Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.33CX Basic pKa: 3.44CX LogP: 1.52CX LogD: 1.52
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.48Np Likeness Score: -0.40

References

1.  (2018)  Atg7 inhibitors and the uses thereof, 

Source